Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Mazdutide

A Study Comparing IBI362 vs Semaglutide in Chinese Overweight or Obese Adults With Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)

Innovent · Phase 3 · Active, not recruiting · Enrollment 479

NCT06884293

ArmPopulationDoseWeeksEstimandWeight change
SemaglutideObesity or overweightn/r4n/rn/r
IBI362Obesity or overweightn/r4n/rn/r